Apnews
Published November 12, 2026 · Updated November 13, 2026
Trump administration will fund new research on controversial psychedelic drug ibogaine
. The effort announced Thursday includes nearly $5 million to lay the groundwork for U.S. studies of ibogaine .
Surfaced by 2 Google Alerts
- Ibogaine
- Psychedelics europe